tiprankstipranks
Advertisement

EFG - ETF AI Analysis

Compare

Top Page

EFG

iShares MSCI EAFE Growth ETF (EFG)

Rating:65Neutral
Price Target:
EFG (iShares MSCI EAFE Growth ETF) has a solid overall rating, largely driven by high-quality growth companies like ASML, AstraZeneca, Novartis, LVMH, Hitachi, and ABB, which all show strong financial performance, healthy balance sheets, and generally positive outlooks. Some holdings such as SAP, Schneider Electric, and Commonwealth Bank of Australia face issues like bearish technical trends, high valuations, or leverage and cash flow concerns, which slightly weigh on the fund’s rating. The main risk factor is that many top holdings are priced at premium valuations, so the ETF is somewhat exposed to overvaluation risk if growth expectations are not met.
Positive Factors
Strong Recent Short-Term Performance
The ETF has shown strong gains over the past month and a positive return so far this year, indicating solid recent momentum.
Leading Growth Companies in Top Holdings
Several of the largest positions, such as ASML, ABB, and Siemens Energy, have delivered strong year-to-date performance, helping drive the fund’s returns.
Broad International Diversification
Holdings spread across many developed markets like Japan, the UK, France, Germany, and others help reduce reliance on any single country’s economy.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially low for a passive ETF, which slightly reduces the net return investors keep over time.
Exposure to Some Weak Top Holdings
A few major positions, including SAP, LVMH, and Hitachi, have shown weak year-to-date performance, which can drag on overall results if the trend continues.
Limited U.S. Market Exposure
With only a small portion of assets in U.S. stocks, the ETF may lag global benchmarks during periods when the U.S. market outperforms other regions.

EFG vs. SPDR S&P 500 ETF (SPY)

EFG Summary

The iShares MSCI EAFE Growth ETF (EFG) is a fund that follows the MSCI EAFE Growth Index, focusing on fast-growing companies in developed markets outside the U.S. and Canada, such as Japan, the UK, and Europe. It holds well-known international names like ASML Holding and AstraZeneca, giving you broad exposure to many industries, including technology, health care, and industrials. An investor might choose EFG to seek long-term growth while diversifying beyond the U.S. stock market. A key risk is that growth stocks and foreign markets can be more volatile, so the share price can rise and fall significantly over time.
How much will it cost me?The iShares MSCI EAFE Growth ETF (EFG) has an expense ratio of 0.36%, meaning you’ll pay $3.60 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it tracks a growth-focused index, which requires more active management compared to broad, passively managed funds. It’s still considered reasonable for the specialized exposure it provides.
What would affect this ETF?The iShares MSCI EAFE Growth ETF could benefit from continued innovation and expansion in technology and industrial sectors, which make up a significant portion of its holdings. However, challenges like rising interest rates or economic slowdowns in developed markets outside North America could negatively impact growth-focused companies. Additionally, regulatory changes or geopolitical tensions in regions like Europe or Asia may affect the ETF’s performance.

EFG Top 10 Holdings

EFG leans heavily on a handful of international growth champions, with Dutch chip-equipment giant ASML setting the pace as a rising star in the portfolio. Industrial names like Schneider Electric, ABB, and Siemens Energy are also powering ahead, giving the fund a strong tilt toward Europe’s industrial and automation theme. On the flip side, SAP and luxury powerhouse LVMH have been losing steam lately, acting as mild brakes on performance. Overall, this is a developed-markets ex-U.S. story, dominated by European growth and industrial innovation.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV5.40%$809.08M€477.33B106.32%
76
Outperform
AstraZeneca2.86%$428.02M$292.69B32.74%
80
Outperform
Novartis AG2.69%$403.07MCHF207.57B22.14%
80
Outperform
SAP SE1.76%$263.95M€171.96B-40.47%
66
Neutral
Schneider Electric1.74%$260.21M€155.45B27.66%
62
Neutral
Siemens Energy1.58%$236.11M€159.84B171.79%
72
Outperform
ABB Ltd1.52%$228.12MCHF140.24B78.92%
78
Outperform
Hitachi,Ltd.1.51%$225.71M¥23.65T25.90%
77
Outperform
Advantest1.46%$219.19M¥20.54T381.96%
75
Outperform
LVMH Moet Hennessy Louis Vuitton1.34%$200.31M€234.45B-7.00%
78
Outperform

EFG Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
116.46
Positive
100DMA
117.07
Positive
200DMA
114.21
Positive
Market Momentum
MACD
0.66
Positive
RSI
49.77
Neutral
STOCH
53.53
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFG, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 118.81, equal to the 50-day MA of 116.46, and equal to the 200-day MA of 114.21, indicating a neutral trend. The MACD of 0.66 indicates Positive momentum. The RSI at 49.77 is Neutral, neither overbought nor oversold. The STOCH value of 53.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for EFG.

EFG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$15.12B0.36%
65
Neutral
$177.92B0.07%
65
Neutral
$74.66B0.32%
66
Neutral
$29.52B0.33%
67
Neutral
$11.15B0.20%
65
Neutral
$10.48B0.24%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EFG
iShares MSCI EAFE Growth ETF
117.50
13.97
13.49%
IEFA
iShares Core MSCI EAFE ETF
EFA
iShares MSCI EAFE ETF
EFV
iShares MSCI EAFE Value ETF
ESGD
iShares ESG Aware MSCI EAFE ETF
JIRE
JPMorgan International Research Enhanced Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement